A survey from “Great Place to Work” predicted that by 2028, the healthcare industry in India would have grown to $320 billion. By 2030, the biotechnology industry hopes to reach $300 billion, while the pharmaceutical industry anticipates reaching $130 billion.
According to the research, strong worldwide expansion, heightened industry consolidation, and the influx of investments exploiting India’s trained workforce are the main drivers of the healthcare sector’s growth.
85% of top workplaces made investments in staff development initiatives in 2024, up from 73% the previous year. The report continued that to stay ahead, companies need to focus more on developing career development routes, developing leaders who are prepared for the future, and improving their methods for luring and keeping top personnel.
The expansion of the healthcare industry is supported by training programs that give staff members access to new tools, therapists, and learning environments in addition to flexible work schedules and chances for cross-departmental mobility. The pharmaceutical industry’s success is mostly attributable to the development of workforce skills, ongoing education, and the adoption of organized processes that support innovation and performance-based career advancement.
The survey has identified Alkem Laboratories, Cipla, and Max Healthcare Institute as the best workplaces in these sectors due to their outstanding employee satisfaction and culture.
Companies in the pharmaceutical and healthcare industries, according to the research, are not just concerned with offering training opportunities; they also make sure that pay is competitive, adjusted to reflect changes in the market, and handled fully transparently. “Furthermore, these organizations are dedicated to establishing bias-free processes, maintaining fairness, and fostering an equity culture at all levels,” the research continued.
